Underlying mechanisms involved in progesterone-induced relaxation to the pig bladder neck

Eur J Pharmacol. 2014 Jan 15:723:246-52. doi: 10.1016/j.ejphar.2013.11.025. Epub 2013 Dec 1.

Abstract

Progesterone increases bladder capacity and improves the bladder compliance by its relaxant action on the detrusor. A poor information, however, exists concerning to the role of this steroid hormone on the bladder outflow region contractility. This study investigates the progesterone-induced action on the smooth muscle tension of the pig bladder neck. To this aim, urothelium-denuded bladder neck strips were mounted in myographs for isometric force recordings and for simultaneous measurements of intracellular Ca(2+) concentration ([Ca(2+)]i) and tension. On phenylephrine (PhE)-precontracted strips, progesterone produced concentration-dependent relaxations only at high pharmacological concentrations. The blockade of progesterone receptors, nitric oxide (NO) synthase, guanylyl cyclase, large conductance Ca(2+)-activated K(+) (BKCa) or ATP-dependent K(+) (KATP) channels reduced the progesterone relaxations. The presence of the urothelium and the inhibition of cyclooxygenase (COX), intermediate- and small-conductance Ca(2+)-activated K(+) channels failed to modify these responses. In Ca(2+)-free potassium rich physiological saline solution, progesterone inhibited the contraction to CaCl2 and to the L-type voltage-operated Ca(2+) (VOC) channel activator BAY-K 8644. Relaxation induced by progesterone was accompanied by simultaneous decreases in smooth muscle [Ca(2+)]i. These results suggest that progesterone promotes relaxation of pig bladder neck through smooth muscle progesterone receptors via cGMP/NO pathway and involving the activation of BKCa and KATP channels and inhibition of the extracellular Ca(2+) entry through L-type VOC channels.

Keywords: K(+) channels; Pig bladder neck; Progesterone; Smooth muscle relaxation; VOC channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / physiology
  • Cyclooxygenase Inhibitors / pharmacology
  • Female
  • Guanylate Cyclase / antagonists & inhibitors
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Male
  • Muscle Relaxation / drug effects*
  • Muscle Relaxation / physiology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitroarginine / pharmacology
  • Oxadiazoles / pharmacology
  • Potassium / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / physiology*
  • Progesterone / pharmacology*
  • Quinoxalines / pharmacology
  • Receptors, Progesterone / antagonists & inhibitors
  • Receptors, Progesterone / physiology*
  • Swine
  • Urinary Bladder / drug effects*
  • Urinary Bladder / physiology
  • Urothelium / physiology

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Cyclooxygenase Inhibitors
  • Oxadiazoles
  • Potassium Channel Blockers
  • Potassium Channels
  • Quinoxalines
  • Receptors, Progesterone
  • Nitroarginine
  • Progesterone
  • Nitric Oxide Synthase
  • Guanylate Cyclase
  • Potassium
  • Calcium
  • Indomethacin